<DOC>
	<DOCNO>NCT01432158</DOCNO>
	<brief_summary>This open-label phase III clinical trial . The purpose trial investigate detail kinetics immune response Prevenar-13 , pneumococcal conjugate vaccine , compare Pneumovax-II , pneumococcal plain polysaccharide vaccine . With consent , healthy adult ( n=2 group ) age 18 year receive pneumococcal vaccine past receive either vaccine first visit . Blood take vaccination day 0,1,2,4,6,8,10,12,14,16,18,20,23,26,30,35 well 2,6 12 month follow vaccination . With specific consent , small volume blood use store DNA RNA analysis genetic association immune response adverse reaction vaccine well RNA expression follow vaccination . Serum plasma use assess antibody level available whole blood use B cell assay examine immunoglobulin gene usage B cell .</brief_summary>
	<brief_title>Pneumococcal Adult Kinetics Study - Understanding B Cell Response Pneumococcal Vaccines</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Above 18 year age . Participant willing able give inform consent participation nature study explain ; In good health determine : medical history historydirected physical examination clinical judgment investigator Able ( Investigators opinion ) willing comply study requirement include available visit schedule study Willing allow General Practitioner consultant , appropriate , notified participation study . Have previously receive pneumococcal vaccine Have receive vaccination vaccine contain either CRM197 diphtheria toxoid within past 12 month , Have previous ascertain disease cause C. diphtheriae , S. pneumoniae past 5 year document medical note Have history anaphylactic shock , asthma , urticaria allergic reaction previous vaccination know hypersensitivity vaccine component ; Have know suspect autoimmune disease impairment /alteration immune function result ( example ) : Receipt immunostimulants Congenital acquire immunodeficiency , receipt immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month longterm systemic corticosteroid therapy ( prednisolone equivalent two consecutive week within past 3 month ) . Have suspect know HIV infection HIV related disease ; Have receive blood , blood product and/or plasma derivative parenteral immunoglobulin preparation past 3 month Have know bleeding diathesis , condition may associate prolonged bleeding time ; Have condition , , opinion investigator , might interfere evaluation study objective . Participation another clinical trial investigate vaccine , drug , medical device , medical procedure Pregnancy confirm positive pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Invasive pneumococcal disease</keyword>
</DOC>